Determinants of Bladder Cancer Recurrence Study (The DETER Study)

Memorial Sloan Kettering Cancer Center3 sites in 1 country600 target enrollmentMarch 2015

ConditionsBladder Cancer

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Bladder Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Enrollment: 600
Locations: 3
Primary Endpoint: recurrence
Status: Active, not recruiting
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to learn how different lifestyle factors, such as cigarette smoking and body weight, change after a diagnosis of bladder cancer, and how they influence who gets a bladder cancer recurrence and who does not.

Registry

clinicaltrials.gov

Start Date

March 2015

End Date

March 2026

Last Updated

last year

Study Type

Observational

Sex

All

Investigators

Sponsor

Memorial Sloan Kettering Cancer Center

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patients ≥18 years old AND
•Histologically-confirmed non-muscle invasive bladder cancer (NMIBC)

Exclusion Criteria

•Patients are ineligible for the study if they have/had:
•Histologically-confirmed NMIBC diagnosed \>36 months prior to enrollment
•Cystectomy prior to enrollment
•Any condition, which in the opinion of the primary MSK clinician or investigators precludes their ability to provide informed consent or comply with study procedures
•Non English-speaking